• Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis
  • Antimicrobial Susceptibility, Nocardia species
  • Varicella Zoster Virus (VZV) Antibody, IgG and IgM
  • Chlamydia trachomatis NA, Liquid Cytology
  • Immunoreactive Insulin
  • Lynch Syndrome Multi Gene Panel (MLH1, MSH2, MSH6, PMS2 and EPCAM), Genomic Unity®
  • TYMS (Thymidylate Synthetase) Gene Mutation Analysis
  • Carbamazepine, Total, Serum
  • 17-Hydroxyprogesterone, Amniotic fluid
  • Cyclobenzaprine, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
Medical Test

Interpretation
Access to Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis is restricted.